MedPath

FRAXIPARINE INJECTION 1ML

Registration Number: MAL19940631AZ

Approved
Approval ID

b71bcac9ccbf37f2

Registration Number

MAL19940631AZ

Registration Date

Jul 7, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types2 types
Last UpdatedJul 7, 2025

PACKAGING INFORMATION (2)

2Units UnitsAvailable
Package Size: 2Units Units
Status: NPRA Approved
10Units UnitsAvailable
Package Size: 10Units Units
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

HEPARIN GLYCOSAMINOGLYCAN/NADROPARIN CALCIUMActive
Monograph: heparin glycosaminoglycan/nadroparin calcium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

FRAXIPARINE INJECTION 1ML - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform